Ascendobiotech
@ascendobiotech.com
Ascendo Biotechnology is developing novel cancer immunotherapies and functional cures for chronic viral infections through targeting of the innate immune system
Ascendobiotech's Company Logos
Ascendobiotech's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#007CBA
Lochmara
0, 124, 186
200, 100, 36
100, 33, 0, 27
#CAF880
Mindaro
202, 248, 128
83, 90, 74
19, 0, 48, 3
#212121
Mine Shaft
33, 33, 33
0, 0, 13
0, 0, 0, 87
About Ascendobiotech
Ascendo Biotechnology is a fast-growing biotechnology company based in Taiwan. They are dedicated to developing breakthrough therapeutic and preventative medicines, with a focus on cancer immunotherapies and functional cures for chronic viral infections. One of their lead products, ASD141, is an innate immune checkpoint inhibitor that stimulates a controlled, active immune response against solid tumors by blocking a key regulatory protein called TLT-1.
Ascendo Biotechnology also has a diverse pipeline that includes NanoCherub®, a nanocomplex platform technology, which serves as the basis for their early-stage injectable, oral therapeutic, and prophylactic vaccines. With 11 registered patents and a valuation of USD 27. 75 million, Ascendo Biotechnology is rapidly advancing in the field.
They have ambitious plans for the future, including phase I clinical trials for ASD141 and their therapeutic HBV vaccine (ASD253). As a strategic partner, they are actively seeking collaboration opportunities to further accelerate the development and commercialization of their lead oncology drug, ASD141
